SectorBiological Technology
Established Date18/06/2020
Listing Date22/10/2021
ExchangeNASDAQ Stock Exchange
Full-time Employees76
Fiscal Year Ends31/12
Security TypeCommon stock
Office address828 Winter Street
Suite 300
Waltham
MA 02451
Business
IntroductionXilio Therapeutics, Inc., was incorporated in Delaware on June 18, 2020. The company is a clinical-stage biotechnology company that discovers and develops masking immunoecological (I-O) therapies designed to significantly improve outcomes for cancer patients. Leveraging its clinically validated masking technology and capabilities, the company is developing I-O therapies designed to be selectively activated in the tumor microenvironment to achieve long-lasting efficacy without the serious side effects associated with systemically active I-O drugs.
